🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The KRAS crowd targets its next cancer mutations nature.com/articles/d4157… Insightful piece by Asher Mullard on drugging #KRAS beyond G12C mutants in Nature Reviews Drug Discovery #KRASG12D #panKRAS inhibitors, molecular glues, degraders and more to come.

Happy to get our work published in Cancers MDPI .

Moving into another beautiful place to learn how every little action has an #impact on the #medicalcare of #patients with #cancer #Botswana #thinkglobalactlocal #smallchanges

Happy to announce registrations open for National conference of Young Oncologists!

Innovation, enthusiasm and networking - all these will be there, at the Third Edition of National Forum of the Romanian Young Oncologists (RYO). Many thanks to our National Society, menthors and colleagues. Don't wait and register! lnkd.in/dsEhv3he

Opening ceremony of #esmolatinamericasummit 2023 in #Beunosaires in #partnership with AAOC. What a privilege to be here with Andres Cervantes G Curigliano MD PhD #leadership #ESMOLDC

✳️A nice article showing tumor mutation burden alone relatively irrelevant for IO response among MSS GI cancers particularly for MSS CRC❗️ Why?👇 OncoAlert The Colon Club The Colon Club Manju George MVSc PhD Rectal Cancer Survivor UPMC Hillman Cancer Center thelancet.com/journals/lanon…

Happy to be part of Romanian Young Oncologists (RYO) Group and to discuss clinical cases with renowned experts and my smart colleagues at the Third Edition of our Young Oncologists Congress in Sibiu Romania@TeresaSAmaral Silvia B Mosoiu, MD Antonio D'Alessio Salvo Provenzano Daniel Sur

We need more🚦 1️⃣ time to exercise 🏋‍♀️ 2️⃣ time to enjoy nature 🚵‍♀️ 3️⃣ down to earth 🌎 leaders📈 4️⃣ clean energy🌞 But not tabaco! ESMO - Eur. Oncology Pawel Sobczuk Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ Carmen Criscitiello Jon Lim, MRCP PhD

As the world continues to be challenged by the increase of GI cancer diagnoses throughout our communities, the clinical breakthroughs presented during the World GI Congress give you the expertise needed to treat your patients with confidence. We hope to see you in Barcelona

I am excited for the opportunity to share our research findings as POSTER with fellow around the world in GI CANCERS. World Congress on Gastrointestinal Cancer is great! Stimulating discussions, exchanging ideas, and gaining valuable insights from the diverse community of researchers and professionals attending

If you are an ESMO - Eur. Oncology #member you have now the chance to choose #ESMO Nomination #Committee The Electronic Ballot Vote is Now Open 📥 You can find out more about the candidates & view their documentation here → esmo.org/about-esmo/nom…

🩸🧬ctDNA can effectively detect MSI-H across 21 cancers. 🩸🧬Patients with this marker who received immunotherapy showed better treatment outcomes across most cancers. ⏲️Quick, non-invasive, and promising for guiding treatment decisions! 🧬💉📈 #CancerResearch

Attending #Esmo23? Here is why U should come 2 #melanoma & other #skincancers track sessions. Exciting data in #neoadjuvant & #adjuvant setting #non-MelSM & #brainmets I am looking forward to seeing friends & colleagues, #networking & discussing #Science with impact on pts care!

@EU2024BE The largest #burnout survey in 2017 among European #YoungOncologists by ESMO confirmed that overall burnout prevalence was exceeding 70% with significant notable geographical differences (Susana Banerjee et al).

🤩 what a pleasure to help providing news from #ASCO24 together with such amazing people ❤️ Tom Powles Myriam Chalabi Jarushka Naidoo Teresa Amaral, MD, PhD Ben Westphalen Pawel Sobczuk Annals of Oncology

The amazing #group that made the discussion during our #mentorthementor session today ESMO - Eur. Oncology #ESMO24 Thanks to the mentors for coming & sharing with us their expertise #mentorshipmatters Vlad Adrian Afrasanie #AnaBosch Women4Oncology Lizzy Smyth Marina Garassino

Welcome to the official page of Romanian Young Oncologists (RYO)! 🎉 We're excited to have you in our community of young oncologists in Romania. As a division of SNOMR, RYO is committed to supporting the professional growth of young oncology specialists!

Happy to share our latest #review on #neoadjuvantimmunotherapy: an extensive overview of current and emerging data in NSCLC, TNBC, GI + bladder cancers, melanoma and many more: written with close friends and KOLs published today in Nature Cancer MarleenKokLab doi.org/10.1038/s43018…